| Company Name: |
ChemShuttle, Inc. |
| Tel: |
0510-83588313-811 18800520310 |
| Email: |
sales@chemshuttle.com |
Razuprotafib manufacturers
- Razuprotafib
-
- $253.00
-
2026-07-27
- CAS:1008510-37-9
- Purity: 99.76%
- Supply Ability: 10g
|
| | Razuprotafib Basic information |
| Product Name: | Razuprotafib | | Synonyms: | Razuprotafib;acute,Phosphatase,Tie-2,AKB 9778,inhibit,Inhibitor,nephropathy,kidney,Razuprotafib,injury,diabetic,AKB9778;Carbamic acid, N-[(1S)-2-oxo-1-(phenylmethyl)-2-[[(1S)-2-[4-(sulfoamino)phenyl]-1-[2-(2-thienyl)-4-thiazolyl]ethyl]amino]ethyl]-, C-methyl ester;(4-((S)-2-((S)-2-((methoxycarbonyl)amino)-3-phenylpropanamido)-2-(2-(thiophen-2-yl)thiazol-4-yl)ethyl)phenyl)sulfamic acid;Razuprotafib, 10 mM in DMSO;Razuprotafib/AKB-9778 | | CAS: | 1008510-37-9 | | MF: | C26H26N4O6S3 | | MW: | 586.71 | | EINECS: | | | Product Categories: | | | Mol File: | 1008510-37-9.mol |  |
| | Razuprotafib Chemical Properties |
| density | 1.450±0.06 g/cm3(Predicted) | | solubility | DMSO:100.0(Max Conc. mg/mL);170.44(Max Conc. mM) | | pka | -9.40±0.27(Predicted) | | form | Solid | | color | White to off-white |
| | Razuprotafib Usage And Synthesis |
| Uses | Razuprotafib is a known VE-PTP inhibitor that can effectively interact with the active site of VE-PTP to inhibit the activity of VE-PTP. | | in vivo | Razuprotafib (20 mg/kg; s.c.) promotes phosphorylation of TIE2 in retinal endothelial cells in vivo[1].
Razuprotafib (10-20 mg/kg; s.c.; twice daily for 7 days) suppresses subretinal neovascularization (NV)[1]. |
| | Razuprotafib Preparation Products And Raw materials |
|